The Clorox Company (NYSE:CLX) Shares Sold by Larson Financial Group LLC

Larson Financial Group LLC trimmed its position in shares of The Clorox Company (NYSE:CLX) by 9.2% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,778 shares of the company’s stock after selling 283 shares during the period. Larson Financial Group LLC’s holdings in Clorox were worth $396,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of CLX. Wedge Capital Management L L P NC bought a new stake in shares of Clorox during the fourth quarter valued at approximately $1,794,000. Mengis Capital Management Inc. increased its position in Clorox by 224.2% in the 4th quarter. Mengis Capital Management Inc. now owns 6,579 shares of the company’s stock valued at $938,000 after acquiring an additional 4,550 shares during the period. Stock Yards Bank & Trust Co. increased its position in Clorox by 3.1% in the 4th quarter. Stock Yards Bank & Trust Co. now owns 23,596 shares of the company’s stock valued at $3,365,000 after acquiring an additional 713 shares during the period. Significant Wealth Partners LLC bought a new stake in Clorox during the 4th quarter valued at $826,000. Finally, Handelsbanken Fonder AB boosted its position in Clorox by 100.2% during the 4th quarter. Handelsbanken Fonder AB now owns 56,440 shares of the company’s stock worth $8,048,000 after acquiring an additional 28,245 shares during the period. Institutional investors own 78.53% of the company’s stock.

Clorox Trading Up 0.6 %

NYSE:CLX opened at $145.98 on Wednesday. The stock’s 50-day moving average is $149.68 and its two-hundred day moving average is $142.23. The company has a debt-to-equity ratio of 11.37, a current ratio of 0.89 and a quick ratio of 0.57. The stock has a market cap of $18.12 billion, a PE ratio of 231.72, a price-to-earnings-growth ratio of 2.29 and a beta of 0.43. The Clorox Company has a fifty-two week low of $114.68 and a fifty-two week high of $178.21.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Thursday, February 1st. The company reported $2.16 EPS for the quarter, beating analysts’ consensus estimates of $1.08 by $1.08. Clorox had a net margin of 1.09% and a return on equity of 319.41%. The firm had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $1.80 billion. During the same period in the previous year, the firm posted $0.98 earnings per share. The firm’s revenue was up 16.0% on a year-over-year basis. As a group, equities research analysts forecast that The Clorox Company will post 5.52 earnings per share for the current fiscal year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 10th. Investors of record on Wednesday, April 24th will be given a dividend of $1.20 per share. The ex-dividend date of this dividend is Tuesday, April 23rd. This represents a $4.80 dividend on an annualized basis and a yield of 3.29%. Clorox’s payout ratio is 761.92%.

Analysts Set New Price Targets

CLX has been the topic of a number of research analyst reports. DA Davidson reissued a “neutral” rating and set a $162.00 price target on shares of Clorox in a report on Wednesday, April 17th. Citigroup lowered their target price on shares of Clorox from $165.00 to $155.00 and set a “neutral” rating on the stock in a research note on Tuesday, April 16th. Barclays reduced their price target on shares of Clorox from $148.00 to $136.00 and set an “underweight” rating for the company in a research note on Wednesday, April 10th. Morgan Stanley reiterated an “equal weight” rating and set a $160.00 price objective on shares of Clorox in a research note on Tuesday, March 26th. Finally, UBS Group upped their target price on Clorox from $145.00 to $170.00 and gave the stock a “neutral” rating in a research report on Friday, February 2nd. Four equities research analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $148.63.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.